Adicet Bio (ACET) Proxy filing summary

Executive summary

• Annual meeting scheduled for June 17, 2026, with voting available online or virtually.

• Shareholders are encouraged to review proxy materials and vote by June 16, 2026.

Voting matters and shareholder proposals

• Election of three class II directors for a three-year term ending at the 2029 annual meeting.

• Advisory vote to ratify executive compensation for named executive officers.

• Ratification of KPMG LLP as independent registered public accounting firm for fiscal year ending December 31, 2026.

• Other business may be addressed as appropriate during the meeting.

Board of directors and corporate governance

• Nominees for director positions include Jeffrey Chodakewitz, M.D., Steve Dubin, J.D., and Michael Grissinger.